AMBEY

Ambey Laboratories Share Price

 

 

Start SIP in AMBEY

Start SIP

Performance

  • Low
  • ₹42
  • High
  • ₹42
  • 52 Week Low
  • ₹31
  • 52 Week High
  • ₹72
  • Open Price₹42
  • Previous Close₹43
  • Volume2,000

Investment Returns

  • Over 1 Month -5.35%
  • Over 3 Month + 0.85%
  • Over 6 Month + 9.62%
  • Over 1 Year -34.64%

Smart Investing Starts Here Start SIP with Ambey Laboratories for Steady Growth!

Invest Now

Ambey Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 104
  • P/B Ratio
  • 1.3
  • Average True Range
  • 2.28
  • EPS
  • 1.89
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.15
  • RSI
  • 55.31
  • MFI
  • 76

Ambey Laboratories Financials

Ambey Laboratories Technicals

EMA & SMA

Current Price
₹41.60
-1.4 (-3.26%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹41.12
  • 50 Day
  • ₹41.08
  • 100 Day
  • ₹41.60
  • 200 Day
  • ₹45.72

Resistance and Support

43 Pivot Speed
  • R3 43.00
  • R2 43.00
  • R1 43.00
  • S1 43.00
  • S2 43.00
  • S3 43.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ambey Laboratories Ltd has an operating revenue of Rs. 131.79 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 5% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 5% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Diversified Operations and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ambey Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-06-27 To consider Fund Raising (Revised)
2025-05-20 Audited Results & Others To consider other business matters. (Revised)
2025-01-30 To consider Fund Raising & Others To consider other business matters.
2024-11-13 Quarterly Results

Ambey Laboratories F&O

Ambey Laboratories Shareholding Pattern

70.15%
0%
0.03%
22.37%
7.45%

Ambey Laboratories FAQs

Ambey Laboratories share price is ₹41 As on 31 December, 2025 | 13:58

The Market Cap of Ambey Laboratories is ₹103.8 Cr As on 31 December, 2025 | 13:58

The P/E ratio of Ambey Laboratories is 21.7 As on 31 December, 2025 | 13:58

The PB ratio of Ambey Laboratories is 1.3 As on 31 December, 2025 | 13:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23